The three dimensions of functional T-cell tolerance: From research to practice

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 1, 2012, Pages 508-511

  Hünefeld, Christian ^a   Mezger, Markus ^a   Röcken, Martin ^a   Röcken, Michael ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Veterinary Clinic   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; FLUORESCENCE IN SITU HYBRIDIZATION; FUNCTIONAL T CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LICHEN PLANUS; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SKIN INFLAMMATION; T LYMPHOCYTE;

EID: 84856886545     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.465     Document Type: Note

References (45)

1. Gudjonsson JE, Ding J, Li X et al. (2009) Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol 129:2795-804
2. Handy DE, Castro R, Loscalzo J (2011) Epigenetic modifications: Basic mechanisms and role in cardiovascular disease. Circulation 123:2145-56
3. Hodge DR, Xiao W, Clausen PA et al. (2001) Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 276:39508-11
4. Karason A, Gudjonsson JE, Upmanyu R et al. (2003) A susceptibility gene for psoriatic arthritis maps to chromosome 16q: Evidence for imprinting. Am J Hum Genet 72:125-31 (Pubitemid 36056848)
5. Khavari DA, Sen GL, Rinn JL (2010) DNA methylation and epigenetic control of cellular differentiation. Cell Cycle 9:3880-3
6. Rahman P, Gladman DD, Schentag CT et al. (1999) Excessive paternal transmission in psoriatic arthritis. Arthritis Rheum 42:1228-31 (Pubitemid 29268960)
7. Rakyan VK, Down TA, Balding DJ et al. (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12:529-41
8. Roberson EDO, Liu Y, Ryan C et al. (2012) A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol 132:583-92
9. Sen GL, Reuter JA, Webster DE et al. (2010) DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 463:563-7
10. Traupe H, van Gurp PJ, Happle R et al. (1992) Psoriasis vulgaris, fetal growth, and genomic imprinting. Am J Med Genet 42:649-54
11. Zaidi SK, Young DW, Montecino M et al. (2011) Bookmarking the genome: Maintenance of epigenetic information. J Biol Chem 286:18355-6
12. Biedermann T, Zimmermann S, Himmelrich H et al. (2001) IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2:1054-60 (Pubitemid 33069501)
13. Bielekova B, Goodwin B, Richert N et al. (2000) Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand. Nat Med 10:1167-75
14. Egeter O, Mocikat R, Ghoreschi K et al. (2000) Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice. Cancer Res 60:1515-20 (Pubitemid 30183417)
15. Felgentreff K, Perez-Becker R, Speckmann C et al. (2011) Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol 141:73-82
16. Getsios S, Waschke J, Borradori L et al. (2010) From cell signaling to novel therapeutic concepts: International pemphigus meeting on advances in pemphigus research and therapy. J Invest Dermatol 130:1764-8
17. Ghoreschi K, Thomas P, Breit S et al. (2003) Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9:40-6 (Pubitemid 36098258)
18. Ghoreschi K, Brück J, Kellerer C et al. (2011) Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med 208:2291-303
19. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263-71 (Pubitemid 47069537)
20. Griffiths CE, Strober BE, van de Kerkhof P et al. (2010) Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 362:118-28
21. Gutermuth J, Nograles K, Miyagawa F et al. (2009) Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and Valpha2 down-regulation. J Immunol 183:3130-8
22. Hoetzenecker W, Echtenacher B, Guenova E et al. (2012) ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med 18:128-134
23. Hunder NN, Wallen H, Cao J et al. (2008) Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med 358:2698-703 (Pubitemid 351860862)
24. Kappos L, Gold R, Miller DH et al. (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: A multicentre, randomised, doubleblind, placebo-controlled phase IIb study. Lancet 372:1463-72
25. Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory diease reloaded: A clinical perspective. Cell 140:784-90
26. Kisielow P, Blüthmann H, Staerz UD et al. (1988) Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742-6
27. Kwon ED, Foster BA, Hurwitz AA et al. (1999) Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy. Proc Natl Acad Sci USA 96:15074-9 (Pubitemid 30019767)
28. Lahl K, Loddenkemper C, Drouin C et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204: 57-63 (Pubitemid 46148756)
29. Lang KS, Caroli CC, Muhm A et al. (2001) HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/ MART1. J Invest Dermatol 116:891-7 (Pubitemid 32554374)
30. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045 (Pubitemid 24140436)
31. Moskophidis D, Lechner F, Pircher H et al. (1993) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-61 (Pubitemid 23125981)
32. Müller-Hermelink N, Braumuller H, Pichler B et al. (2008) TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13:507-18 (Pubitemid 351763899)
33. Paek SY, Miyagawa F, Zhang H et al. (2012) Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity. J Invest Dermatol 132:677-86
34. Racke MK, Bonomo A, Scott DE et al. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-6 (Pubitemid 24328587)
35. Richardson LE, Dudhia J, Clegg PD et al. (2007) Stem cells in veterinary medicine-attempts at regenerating equine tendon after injury. Trends Biotechnol 25:409-16 (Pubitemid 350147117)
36. Robert C, Thomas L, Bondarenko I et al. (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364:2517-26
37. Röcken M, Urban JF, Shevach EM (1992) Infection breaks T-cell tolerance. Nature 359:79-82
38. Röcken M, Urban J, Shevach EM (1994) Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J Exp Med 179:1885-93 (Pubitemid 24155669)
39. Sadick MD, Heinzel FP, Holaday BJ et al. (1990) Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 171:115-27 (Pubitemid 20040603)
40. Saibil SD, Deenick EK, Ohashi PS (2007) The sound of silence: Modulating anergy in T lymphocytes. Curr Opin Immunol 19:658-64 (Pubitemid 350236809)
41. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nat Immunol 6:345-52 (Pubitemid 41716771)
42. Santambrogio L, Hochwald GM, Leu CH et al. (1993) Antagonistic effects of endogenous and exogenous TGF-beta and TNF on autoimmune diseases in mice. Immunopharmacol Immunotoxicol 15:461-78 (Pubitemid 23258312)
43. Schönrich G, Kalinke U, Momburg F et al. (1991) Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293-304 (Pubitemid 121006059)
44. Shevach EM (2011) Biological functions of regulatory T cells. Adv Immunol 112:137-76
45. Ziegler A, Heidenreich R, Braumuller H et al. (2009) EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion. Blood 113:3494-502